Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin.
about
Updates on the Clinical Trials in Diabetic Macular EdemaGlucocorticoids in the management of peritumoral brain edema: a review of molecular mechanismsIntestinal barrier function: molecular regulation and disease pathogenesisIncrease in the tight junction protein claudin-1 in intestinal inflammationShort-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case seriesClinical trials on corticosteroids for diabetic macular edemaPharmacologic therapy for diabetic retinopathy.Emerging pharmacotherapies for diabetic macular edema.Endoplasmic reticulum stress and diabetic retinopathy.The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular EdemaStretch and Shear Interactions Affect Intercellular Junction Protein Expression and Turnover in Endothelial Cells.Vitreous inflammatory factors in macular edema with central retinal vein occlusion.bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain InjuryEffect of intravitreal bevacizumab on diabetic macular edema with hard exudates.Etiology and treatment of the inflammatory causes of cystoid macular edema.Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury.Pathophysiology and treatment of diabetic retinopathy.Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONOThe role of mitosis in LDL transport through cultured endothelial cell monolayers.A novel model for brain iron uptake: introducing the concept of regulationSteroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series.Resistin increases monolayer permeability of human coronary artery endothelial cells.Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literatureFoveal sensitivity and morphology in major and macular branch retinal vein occlusionEffect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Current and future approaches in the prevention and treatment of diabetic retinopathy.Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy.Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature.The dexamethasone drug delivery system: indications and evidence.Microvascular transport and tumor cell adhesion in the microcirculationFluocinolone acetonide for the treatment of diabetic macular edema.Angiopoietin-1 protects the endothelial cells against advanced glycation end product injury by strengthening cell junctions and inhibiting cell apoptosis.Long-term follow-up of anatomical and functional macular changes after a single intravitreal implant of dexamethasone 0.7 mg for radiation macular edema secondary to proton beam therapy for choroidal melanoma.
P2860
Q26767100-94C1D15E-C38A-46C7-9561-7176D57FAA93Q28075735-5F90C348-9ED4-4B8E-8B29-1E9AAECFF264Q28250081-30DC79AC-DBEA-4375-86D8-45E0691C2FE6Q28577922-7B9F7965-8ACF-488D-86E8-6878245CF083Q31095625-DC19AC0C-AA77-48B7-8898-4590CF4B81BBQ31146864-E13894EE-9C07-429B-85FD-E37F0FB45378Q33194915-F99EFEB7-7CB7-466F-8F07-F8F5ABE02753Q33304852-50726925-DD21-4C37-9C6D-07BB6A84D233Q33352111-B2A6F5A0-9F9C-43D5-B482-417D99AA5127Q33534181-FCD44035-7DAE-4253-80A8-88474E90132BQ33546338-8BDF3DBB-4B3C-46E2-991B-A81CF3869520Q33562320-6B36D9FC-F625-4048-B11B-2DEF3E0A32F4Q33888116-8BBF1DB0-60A4-4603-8C4F-DF5C1C12D267Q33917585-5263800D-43F9-4553-B39D-C6858AB46BA4Q34062356-7276B48C-F5EF-42E2-9EAD-0CBF2B468878Q34077613-8A77B13E-FEA5-423C-9A21-9876D7E598EFQ34372914-0AEA340D-0B96-4AD4-B634-1B4BE279DF0CQ34515842-91FD1143-835E-4605-9C31-510350D03703Q34528134-4D65C0BE-6A6A-4F38-B660-A97345C3EFA6Q34703697-75F39AA5-809E-4496-9B5C-3D50FD6AABCBQ34720419-9DBB252F-8F40-4128-B40C-9B9AC19E0445Q34957468-9819D666-3E9D-42BB-812C-DB8703EE4DE5Q35030923-A96B2981-B15D-4F6F-922F-BAFA15FB5444Q35064503-8DF34013-D208-4E64-B46C-5B902CE50D02Q35080983-8148FF1C-62EE-4B65-A3E8-F8B78FF4BF07Q35828114-802A762D-6462-43C8-8A40-ACC1E0020CF0Q35849738-0D519B32-0F64-494A-9D77-027A33FFCA55Q36311041-B49DCDF5-CA31-44A3-A60F-C40C483374DFQ36341458-2FCFEBFA-3EAB-4422-979C-EE2A3272BF02Q36460747-1D30528E-5983-4FD2-9D76-0D8B40FF3855Q36906893-7D9D3B75-A5C7-4BE3-93C8-1E9D54079E27Q37084522-7016F889-5AD4-462C-A01C-F4B4F08123E3Q37221516-3788E132-B877-4AA7-9E8D-7D037B051D1AQ37416874-9BD427FC-6718-4265-8B8A-FAEB267FDD57Q37600478-8842BF1E-D132-4559-B009-1C902741B990Q37865422-1BC9AB81-28DD-48B1-B12E-1210D339B535Q38000080-EC7A13A4-4BC9-456D-8675-7EDB0507D1ABQ38648612-AA4261EA-7B72-4308-BC31-68AF11B2FFDCQ38924698-F59C6AE0-393A-4F3B-90CF-42694334B8EBQ39110043-CDCE6983-EA76-4B28-8904-686CAC2B60DA
P2860
Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@en
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@nl
type
label
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@en
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@nl
prefLabel
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@en
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@nl
P2093
P1476
Hydrocortisone decreases retin ...... d phosphorylation of occludin.
@en
P2093
David A Antonetti
Ellen B Wolpert
Lucas DeMaio
Nicole S Harhaj
Russell C Scaduto
P304
P356
10.1046/J.0022-3042.2001.00740.X
P407
P577
2002-02-01T00:00:00Z